(Q40267461)

19 September 2017

title

Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization (English)

1 reference

19 September 2017

1 reference

Andrea Marzi

1

0 references

Stefan Pöhlmann

object named as

Stefan Pöhlmann

series ordinal

3

0 references

author name string

Anja Wegele

series ordinal

2

1 reference

19 September 2017

language of work or name

English

0 references

publication date

13 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

352

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

345-356

1 reference

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Caveola-dependent endocytic entry of amphotropic murine leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Enhancement of enveloped virus entry by phosphatidylserine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Regulated portals of entry into the cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Virus entry: molecular mechanisms and biomedical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Association of the caveola vesicular system with cellular entry by filoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Glycosylation and oligomerization of the spike protein of Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Ebola virus: from discovery to vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Interactions of a vesicular stomatitis virus G protein fragment with phosphatidylserine: NMR and fluorescence studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Mechanism of interference mediated by human parainfluenza virus type 3 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

How Ebola virus infects cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Role of CD4 receptor down-regulation during HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Comprehensive analysis of ebola virus GP1 in viral entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The pH independence of mammalian retrovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

HIV-1 infection and chemokine receptor modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Neutralized vesicular stomatitis virus binds to host cells by a different “receptor”

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

How Viruses Enter Animal Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Entry pathway of vesicular stomatitis virus into different host cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

A system for functional analysis of Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Processing of the Ebola virus glycoprotein by the proprotein convertase furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Functional importance of the coiled-coil of the Ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Epitopes involved in antibody-mediated protection from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

Ebola virus can be effectively neutralized by antibody produced in natural human infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.04.038

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.04.038

1 reference

19 September 2017

1 reference